Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
Resmed Inc has filed a notice for the proposed sale of securities under Rule 144, involving 2,575 common shares with an aggregate market value of approximately $739,289.14. The sale is expected to take place on August 18, 2025, on the NYSE, with John Hernandez, a director of the company, as the account holder. This transaction reflects a routine financial activity and does not indicate any undisclosed adverse information about the company’s operations.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$41.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of equipment related to sleep disorders, respiratory care, and other chronic diseases. The company is known for its innovative solutions in sleep apnea treatment and has a significant market presence in the medical devices sector.
Average Trading Volume: 896,066
Technical Sentiment Signal: Buy
Current Market Cap: A$63.97B
For detailed information about RMD stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money